🌟 New Weight Management Treatment Coming Soon

We’re pleased to share that Bridge View Medical will be offering a new weight management treatment — tirzepatide — starting from early July 2025.

Tirzepatide is a medication already used in diabetes care and is now being offered as part of a new national weight management programme.

💊 What you need to know:

• The service will begin from 23rd June, with full rollout expected by early July.

• Prescribing will be provided by our experienced pharmacist team, with patient support from our Dietician

• This treatment is being offered to patients with a BMI over 40, or over 37.5 if from a BAME background, and who have four weight-related health conditions.

📞 We will proactively contact eligible patients — there’s no need to contact us.

📨 If you submit a query via Klinik, our pharmacist team will review it. If you’re not eligible for the first phase, we’ll let you know by text. Eligible patients will receive a phone call with next steps.

We anticipate some national news coverage about this soon, and we understand patients may have questions — but rest assured, we’ll be in touch if you're part of the first group.

Thank you for your patience and support.